The rising prevalence of sleep disturbances and epilepsy is expected to drive the Asia-Pacific CBD gummies market growth.

Published: Aug 2021

The Asia-Pacific Anti-Microbial Coatings market is anticipated to grow at a considerable CAGR of 28.8% during the forecast period (2021-2027). The factors such as the increasing prevalence of sleep abnormalities and epilepsy among various Asia-Pacific countries population including China is majorly driving the popularity of CBD gummies in the region. For instance, according to a Public Library of Science (PLOS) study published in March 2021, covering 430,422 adolescents in China, out of which 104,802 had sleep disturbances thereby the total prevalence rate was 26%. Adolescents in senior high school (28%, 95%) had a higher prevalence of sleep disturbances than those in junior high school (20%, 95%). Moreover, according to an article published by The Lancet Neurology, there are approximately 10 million epileptics in China. In China, there is a significant treatment gap for epilepsy, which is primarily caused by deficiencies in healthcare delivery and social discrimination due to cultural beliefs about epilepsy, therefore this factor drives the market for CBD gummies that are easy to consume orally. 

Browse the full report description Asia-Pacific CBD Gummies Market Size, Share & Trends Analysis Report by Concentration (High Concentration, and Low Concentration) By Distribution Channel (Online and Offline) Forecast, 2021-2027 at https://www.omrglobal.com/industry-reports/asia-pacific-cbd-gummies-market

Rising acquisitions, product approval, collaborations among the major players in the market also propel the growth of the market. For instance, in May 2019, Elixinol Global Ltd a partnership with Cambrian Alliance (CA), one of the biggest buying groups for independent pharmacies in the UK. The collaboration gives CA members access to Elixinol brand products, an exclusive launch offer package, point of sale material, and staff training. In support of the partnership, Elixinol is developing an interactive training framework for CA members. This framework will assist members in explaining the various benefits of Elixinol products to their customers while also maximizing CBD revenue opportunities.

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered- 

o By Concentration

o By Distribution Channel

  • Competitive Landscape- Elixinol Global Ltd, CV science Inc, Reliva CBD Wellness, and Hemp Bombs. 

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominate the market in the base year?
  • Which segment and region will project the fastest growth in the market?
  • How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Asia-Pacific CBD Gummies Market Report Segment

By Concentration

  • High Concentration
  • Low Concentration

By Distribution Channel

  • Online
  • Offline

Asia-Pacific CBD Gummies Market Report Segment by Geography

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/asia-pacific-cbd-gummies-market